ask="1.250"
ask_size="500"
average_daily_volume="135908"
bid="1.110"
bid_size="100"
book_value="0.333"
change="-0.005"
change_from_200_day_moving_average="-0.424"
change_from_50_day_moving_average="-0.006"
change_from_52_week_high="-2.255"
change_From_52_week_low="0.416"
change_in_percent="-0.407%"
close="1.225"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.810"
ebitda="-19.61M"
eps_estimate_current_year="-0.720"
eps_estimate_next_quarter="-0.150"
eps_estimate_next_year="-0.620"
ex_dividend_date="N/A"
float_shares="25237000"
high="1.300"
high_52_weeks="3.480"
last_trade_date="3/9/2017"
last_trade_price="1.225"
last_trade_size="100"
last_trade_time="3:59pm"
low="1.210"
low_52_weeks="0.809"
market_capitalization="31.15M"
moving_average_200_day="1.649"
moving_average_50_day="1.231"
name="Repros Therapeutics Inc."
notes="N/A"
one_year_target_price="5.250"
open="1.280"
pe_ratio="N/A"
peg_ratio="-0.060"
percent_change_from_200_day_moving_average="-25.692%"
percent_change_from_50_day_moving_average="-0.476%"
percent_change_from_52_week_high="-64.799%"
percent_change_from_52_week_low="+51.422%"
previous_close="1.230"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.694"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="25425000"
short_ratio="3.890"
stock_exchange="NCM"
symbol="RPRX"
volume="95844"
weeks_range_52="0.809 - 3.480"
